A transparent marketplace for pet owners to compare veterinary costs, track medical history, and coordinate prescription fulfillment through trusted partners.

Can I prevent my cat from getting a FISS?

You can reduce the risk by discussing the necessity of each vaccine with your vet and requesting non-adjuvanted versions.

Is a lump after a vaccine always cancer?

No, many lumps are minor inflammatory responses that resolve, but any lump persisting over 3 months must be checked.

Is the tumor contagious to other pets?

No, Feline Injection Site Sarcoma is not contagious and cannot be passed to other animals.

What is the 3-2-1 rule?

It is a guideline: consult a vet if a mass lasts longer than 3 months, is larger than 2cm, or grows 1 month after injection.

Why are limb injections preferred?

Limb injections allow for the possibility of amputation if a tumor develops, whereas tumors on the trunk are often impossible to remove completely.

Are these tumors curable?

Complete surgical removal combined with radiation offers the best chance of long-term control, but recurrence rates remain high.

Understanding Feline Injection Site Sarcoma (FISS)

Feline Injection Site Sarcoma (FISS) is a locally aggressive, malignant neoplasm that develops within the subcutaneous tissues of cats. Often originating at the site of previous vaccinations, these tumors are characterized by their ability to infiltrate surrounding tissues, including muscle and bone. While not all post-injection swellings are cancerous, any persistent lump must be evaluated to differentiate it from other conditions, such as a Sebaceous Gland Tumor or an abscess.

Pathophysiology and Inflammatory Transformation

At the cellular level, FISS is believed to develop through chronic, dysregulated inflammation. When an irritant—typically an adjuvant in a vaccine or a specific medication—is introduced into the subcutaneous space, the body initiates a wound-healing response. In some genetically predisposed individuals, this process goes awry, leading to the uncontrolled proliferation of fibroblasts and myofibroblasts. This process is distinct from systemic cancers like Leukemia, as FISS remains primarily a localized disease for a significant portion of its development.

Anatomical Sites of Involvement

Most tumors occur in the interscapular region, the lateral thoracic wall, or the limbs. Because these tumors are highly infiltrative, their anatomical proximity to vital structures like the spine or brachial plexus can complicate surgical management. The behavior of these sarcomas is often contrasted with other carcinomas, such as Renal Carcinoma or Gastric Carcinoma, due to their unique development within the connective tissue rather than epithelial layers.

Clinical Indicators and Diagnostic Imaging

Recognizing the early signs of FISS is vital. Owners should monitor injection sites for several months post-administration using the '3-2-1' rule: if a mass persists for more than 3 months, is larger than 2 centimeters in diameter, or is increasing in size 1 month after injection, it requires immediate veterinary evaluation. Unlike a Meningioma, which is localized to the cranial vault, FISS is easily accessible for palpation.

Advanced Imaging Protocols

Before surgical excision, veterinarians often utilize advanced imaging like CT scans or MRI to map the infiltration. This determines if the tumor involves the Chondrosarcoma structures of the ribs or if it extends into the thoracic cavity. Staging usually includes thoracic radiographs to rule out distant metastasis, which is less common in FISS than in Anal Sac Adenocarcinoma, but still a critical risk factor.

Therapeutic Interventions and Surgical Management

Surgery remains the gold standard. Wide-margin excision is required, often necessitating the removal of several centimeters of healthy tissue around the mass. In cases where the tumor is limb-based, amputation may be the only way to achieve clean margins. Following surgery, radiation therapy is almost universally recommended to address microscopic disease remaining at the site. This is a significantly more intensive procedure than managing benign growths seen in other species, such as Prostatic Carcinoma or endocrine tumors like Pancreatic Carcinoma.

Prevention and Long-Term Surveillance

Prevention focuses on reducing the frequency of injections and utilizing vaccines without adjuvants where possible. Injecting in the distal limb is now a standard practice, as it allows for the possibility of amputation should a tumor develop. Ongoing management requires frequent palpation of the patient. Owners should be vigilant, as this condition is far more aggressive and localized than the common Feline Mammary Carcinoma.

Feline Injection Site Sarcoma